Gland Pharma Limited (GLAND) — Free Cash Flow Generation Index
Gland Pharma Limited (GLAND) has a Free Cash Flow Generation Index of 0.67x as of September 2025. Free cash flow of Rs3.99 Billion represents 1% of operating cash flow (Rs5.93 Billion). Read how much debt does Gland Pharma Limited carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Gland Pharma Limited Free Cash Flow Generation Index (2017–2026)
Historical FCF Generation Index trend for Gland Pharma Limited across 10 annual periods. Explore Gland Pharma Limited capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Gland Pharma Limited (2017–2026)
Year-by-year Free Cash Flow Generation Index for Gland Pharma Limited. For the full company profile including market capitalisation, see GLAND market cap.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.60x | Rs7.41 Billion | Rs12.31 Billion | Rs4.91 Billion | ▲ +3.8% |
| 2025 | 0.58x | Rs5.30 Billion | Rs9.15 Billion | Rs3.85 Billion | ▼ -4.8% |
| 2024 | 0.61x | Rs6.07 Billion | Rs9.97 Billion | Rs3.90 Billion | ▲ +57.3% |
| 2023 | 0.39x | Rs1.41 Billion | Rs3.64 Billion | Rs2.23 Billion | ▲ +13.9% |
| 2022 | 0.34x | Rs2.69 Billion | Rs7.91 Billion | Rs5.22 Billion | ▼ -45.4% |
| 2021 | 0.62x | Rs3.76 Billion | Rs6.05 Billion | Rs2.29 Billion | ▼ -13.9% |
| 2020 | 0.72x | Rs5.06 Billion | Rs7.01 Billion | Rs1.95 Billion | ▲ +170.3% |
| 2019 | 0.27x | Rs495.11 Million | Rs1.85 Billion | Rs1.36 Billion | ▼ -53.8% |
| 2018 | 0.58x | Rs1.17 Billion | Rs2.02 Billion | Rs851.75 Million | ▼ -23.5% |
| 2017 | 0.76x | Rs3.60 Billion | Rs4.76 Billion | Rs1.16 Billion | — |